EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma

EAACI Position paper on the standardization of nasal allergen challenges

(2018) J. Augé et al.   ALLERGY

EAACI guidelines on allergen immunotherapy: Executive statement

(2018) A. Muraro et al.   ALLERGY

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

(2018) Paul M. O’Byrne et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial

(2018) Marek Jutel et al.   Immunotherapy

Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation

(2018) Anne M. Fitzpatrick et al.   Journal of Allergy and Clinical Immunology-In Practice

Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma

(2018) Ioana Agache et al.   ALLERGY

Recent developments and highlights in biomarkers in allergic diseases and asthma

(2018) Ibon Eguiluz-Gracia et al.   ALLERGY

Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life

(2017) Daniela Posa et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

EAACI guidelines on allergen immunotherapy: Prevention of allergy

(2017) Susanne Halken et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Usefulness of House Dust Mite Nasal Provocation Test in Asthma

(2017) Inseon S. Choi et al.   Allergy Asthma & Immunology Research

Ten-year trends in direct costs of asthma: a population-based study

(2016) H. Tavakoli et al.   ALLERGY

European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment

(2016) M. A. Calderón et al.   ALLERGY

Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy

(2016) Tolly G. Epstein et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma

(2016) Trung N. Tran et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma

(2016) J. Christian Virchow et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

(2016) Antonella Muraro et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics

(2016) Marek Jutel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Measuring the cost of poor asthma control and exacerbations

(2016) Patrick W. Sullivan et al.   JOURNAL OF ASTHMA

Component-Based Allergen-Microarray: Der p 2 and Der f 2 Dust Mite Sensitization Is More Common in Patients With Severe Asthma

(2016) L Sylvestre et al.   JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment

(2016) Pablo Rodríguez del Río et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicine

(2016) Ioana Agache et al.   ALLERGOLOGY INTERNATIONAL

Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting

(2016) J. Hahn-Pedersen et al.   Clinical and Translational Allergy

In vivodiagnosis of allergic diseases-allergen provocation tests

(2015) I. Agache et al.   ALLERGY

Clinical contraindications to allergen immunotherapy: an EAACI position paper

(2015) C. Pitsios et al.   ALLERGY

House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial

(2015) P. Devillier et al.   ALLERGY

IgE antibodies in relation to prevalence and multimorbidity of eczema, asthma, and rhinitis from birth to adolescence

(2015) N. Ballardini et al.   ALLERGY

Characteristics and severity of asthma in children with and without atopic conditions: a cross-sectional study

(2015) Ali Arabkhazaeli et al.   BMC Pediatrics

The global burden of chronic respiratory disease in adults

(2015) P. Burney et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

(2015) Hendrik Nolte et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

International consensus on allergy immunotherapy

(2015) Marek Jutel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Der p 11 Is a Major Allergen for House Dust Mite-Allergic Patients Suffering from Atopic Dermatitis

(2015) Srinita Banerjee et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Sublingual Immunotherapy for Asthmatic Children Sensitized to House Dust Mite

(2015) Wei Liao et al.   MEDICINE

Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy

(2015) Esozia Arroabarren et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma

(2014) L. Wang et al.   ALLERGY

Integrated care pathways for airway diseases (AIRWAYS-ICPs)

(2014) J. Bousquet et al.   EUROPEAN RESPIRATORY JOURNAL

SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial

(2014) F. de Blay et al.   RESPIRATORY MEDICINE

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens

(2014) Florence Trebuchon et al.   Clinical and Translational Allergy

Improving allergy management in the primary care network - a holistic approach

(2013) M. Jutel et al.   ALLERGY

Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy

(2013) Ayfer Yukselen   ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

Bronchial allergen provocation: A useful method to assess the efficacy of specific immunotherapy in children

(2013) Martin Rosewich et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Allergen-Specific Immunotherapy for Pediatric Asthma and Rhinoconjunctivitis: A Systematic Review

(2013) J. M. Kim et al.   PEDIATRICS

Mechanisms of Allergen-Specific Immunotherapy and Novel Ways for Vaccine Development

(2013) Marek Jutel et al.   ALLERGOLOGY INTERNATIONAL

Influence of subcutaneous specific immunotherapy on drug costs in children suffering from allergic asthma

(2013) Thomas Reinhold et al.   Clinical and Translational Allergy

Untangling asthma phenotypes and endotypes

(2012) I. Agache et al.   ALLERGY

Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy

(2012) Iwona Stelmach et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus

(2012) Manuel Soto-Quiros et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Research needs in allergy: an EAACI position paper, in collaboration with EFA

(2012) Nikolaos G Papadopoulos et al.   Clinical and Translational Allergy

Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes

(2011) Linda Cox et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Effect of One-Year Subcutaneous and Sublingual Immunotherapy on Clinical and Laboratory Parameters in Children with Rhinitis and Asthma: A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy Study

(2011) Ayfer Yukselen et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome

(2011) Jan Lötvall et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: A randomized controlled trial

(2010) Stefan Zielen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma

(2010) Marc Massanari et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta-analysis

(2009) E. Compalati et al.   ALLERGY

An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

(2009) Helen K. Reddel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Inflammatory phenotypes in adult asthma: clinical applications

(2009) Peter Gerard Gibson   Clinical Respiratory Journal

National income, self-reported wheezing and asthma diagnosis from the World Health Survey

(2009) G. Sembajwe et al.   EUROPEAN RESPIRATORY JOURNAL

A Population-based Clinical Study of Allergic and Non-allergic Asthma

(2009) Thomas Bøllingtoft Knudsen et al.   JOURNAL OF ASTHMA

Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)

(2009) C K W Lai et al.   THORAX

Economic burden of asthma: a systematic review

(2009) Katayoun Bahadori et al.   BMC Pulmonary Medicine

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

(2008) J. Bousquet et al.   ALLERGY

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal